Daniela Licht

Title: Daniela Licht: Innovator in Pharmaceutical Formulations

Introduction

Daniela Licht is a prominent inventor based in Giv′at-Shmuel, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release formulations. Her work focuses on improving the efficacy and delivery of anti-epileptic medications.

Latest Patents

One of Daniela Licht's notable patents is for a sustained release formulation of carbamazepine. This invention provides a pharmaceutical preparation in tablet form, where the active ingredient is an anti-epileptic medication. The formulation consists of carbamazepine particles coated with a single hydrophobic layer and is designed to be in a disintegrating tablet form. This innovative approach enhances the delivery and effectiveness of carbamazepine, benefiting patients who require this medication.

Career Highlights

Daniela Licht is associated with Taro Pharmaceutical Industries Limited, a company known for its commitment to developing high-quality pharmaceutical products. Her work at Taro has allowed her to contribute to advancements in medication formulations, particularly for those suffering from epilepsy.

Collaborations

Throughout her career, Daniela has collaborated with talented professionals in her field, including Marina Zholkoysky and Roman Kaplan. These collaborations have fostered an environment of innovation and have led to the successful development of new pharmaceutical solutions.

Conclusion

Daniela Licht's contributions to the pharmaceutical industry, particularly through her patent for a sustained release formulation of carbamazepine, highlight her role as an innovator. Her work continues to impact the lives of patients requiring effective anti-epileptic treatments.